NCT06870591 Pivotal Study for the Cardiac Performance System (CPS)
| NCT ID | NCT06870591 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sensydia Corporation |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-04-22 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-04-22 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization. The study compares CPS measurements to invasive measurements to assess agreement and potential clinical utility.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Scheduled for clinically indicated right heart catheterization * Ability to provide informed consent Exclusion Criteria: * Heart transplant recipients * Patients with a left ventricular assist device (LVAD) * Presence of external devices (e.g., Holter monitors) or surgical scars/wounds that interfere with CPS measurements * Measurement concerns related to data reliability or quality
Frequently Asked Questions
Who can join the NCT06870591 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06870591 currently recruiting?
Yes, NCT06870591 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sensydia Corporation to inquire about joining.
Where is the NCT06870591 trial being conducted?
This trial is being conducted at Huntsville, United States, Evanston, United States, Hackensack, United States, Neptune City, United States and 6 additional locations.
Who is sponsoring the NCT06870591 clinical trial?
NCT06870591 is sponsored by Sensydia Corporation. The trial plans to enroll 1,000 participants.